Bayer stock continues rout after $2 billion award in Roundup trial

74

Shares in Bayer fell as much as 5 percent on Tuesday after a jury awarded more than $2 billion to a California couple in the largest U.S. jury verdict against the company over allegations its Roundup weed killer causes cancer.

http://feeds.reuters.com/~r/reuters/healthNews/~3/tVkH078i410/bayer-stock-continues-rout-after-2-billion-award-in-roundup-trial-idUSKCN1SK0LQ

- Advertisement -